Used in synthesis of Finasteride (5α-reductase inhibitor)

| Name | N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE |
| CAS | 131267-80-6 |
| Synonyms | Fisteride Impurity 19; F6 Finasteride Intermediate; 17β-(tert-Butylcarbamoyl)androst-4-en-3-one; N-tert-butyl-3-oxo-4-androsten-17β-carboxamide, etc. |
| Molecular Formula | C₂₄H₃₇NO₂ |
| Molecular Weight | 371.56 |
| Appearance | White to off-white solid |
| Boiling Point | 540.0 ± 50.0 °C (Predicted) |
| Density | 1.07 ± 0.1 g/cm³ (Predicted) |
| pKa | 16.10 ± 0.60 (Predicted) |
| Storage Temp. | Ambient storage (light-protected, dry) |
| Solubility | Sparingly soluble in organic solvents (e.g., DMSO, ethanol) |
| Form | Powder |
| Usage | Drug Intermediate: Used in synthesis of finasteride (5α-reductase inhibitor); Impurity Reference: Quality control in pharmaceutical analysis. |
| Synthesis | Prepared via amideification of androst-4-en-3-one with tert-butylamine using coupling agents (e.g., EDC/DCC), followed by purification (recrystallization/column chromatography). |
| Regulatory Status | Not explicitly listed (consult regional regulations for specific applications). |
请到「后台-用户-个人资料」中填写个人说明。
© 2026. All Rights Reserved. Theme By XinTheme